These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 24504799)

  • 1. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
    Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
    Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
    Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
    Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound IL-6R is upregulated on Th17 cells and inhibits Treg cell migration by regulating post-translational modification of VASP in autoimmune arthritis.
    Yan S; Golumba-Nagy V; Kotschenreuther K; Thiele J; Refaian N; Shuya D; Gloyer L; Dittrich-Salamon M; Meyer A; Heindl LM; Kofler DM
    Cell Mol Life Sci; 2021 Dec; 79(1):3. PubMed ID: 34913099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction.
    Moon SJ; Park JS; Woo YJ; Lim MA; Kim SM; Lee SY; Kim EK; Lee HJ; Lee WS; Park SH; Jeong JH; Park SH; Kim HY; Cho ML; Min JK
    Arthritis Rheumatol; 2014 Apr; 66(4):874-85. PubMed ID: 24757140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis.
    Park JS; Kwok SK; Lim MA; Kim EK; Ryu JG; Kim SM; Oh HJ; Ju JH; Park SH; Kim HY; Cho ML
    Arthritis Rheumatol; 2014 Apr; 66(4):918-29. PubMed ID: 24757144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
    McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
    Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
    Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice.
    Thiolat A; Denys A; Petit M; Biton J; Lemeiter D; Herve R; Lutomski D; Boissier MC; Bessis N
    Cytokine; 2014 Sep; 69(1):87-93. PubMed ID: 25022966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
    Chen L; Wu X; Zhong J; Li D
    BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis.
    Hui W; Yu D; Cao Z; Zhao X
    Int Immunopharmacol; 2019 Mar; 68():226-233. PubMed ID: 30660077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-specificity phosphatase 5 attenuates autoimmune arthritis in mice via reciprocal regulation of the Th17/Treg cell balance and inhibition of osteoclastogenesis.
    Moon SJ; Lim MA; Park JS; Byun JK; Kim SM; Park MK; Kim EK; Moon YM; Min JK; Ahn SM; Park SH; Cho ML
    Arthritis Rheumatol; 2014 Nov; 66(11):3083-95. PubMed ID: 25047518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.
    Sarantopoulos A; Tselios K; Gkougkourelas I; Pantoura M; Georgiadou AM; Boura P
    Arthritis Rheumatol; 2014 Sep; 66(9):2638. PubMed ID: 24891239
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
    Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tocilizumab indeed reduce the frequency of Th17 cells? Comment on the article by Thiolat et al.
    Samson M; Audia S; Ornetti P; Maillefert JF; Janikashvili N; Bonnotte B
    Arthritis Rheumatol; 2014 Sep; 66(9):2639-40. PubMed ID: 24891312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.